Premium
MAT is societally cost‐effective and improves quality of life
Author(s) -
Knopf Alison
Publication year - 2021
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.33027
Subject(s) - (+) naloxone , contingency , cost effectiveness , quality (philosophy) , quality of life (healthcare) , environmental science , operations management , medicine , risk analysis (engineering) , economics , nursing , opioid , linguistics , philosophy , receptor , epistemology
A cost‐effectiveness study has found that medication‐assisted treatment (MAT), combined with contingency management, overdose education and naloxone distribution, was associated with both cost savings and health benefits compared to no treatment.